These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11493330)

  • 21. Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction.
    Sun L; Chen F; Shi W; Qi L; Zhao Z; Zhang J
    Diagn Pathol; 2014 Jul; 9():125. PubMed ID: 25029906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of {beta}-catenin, MUC1 and c-met in diffuse-type gastric carcinomas: correlations with tumour progression and prognosis.
    Retterspitz MF; Mönig SP; Schreckenberg S; Schneider PM; Hölscher AH; Dienes HP; Baldus SE
    Anticancer Res; 2010 Nov; 30(11):4635-41. PubMed ID: 21115917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear accumulation of beta-catenin protein in Wilms' tumours.
    Koesters R; Niggli F; von Knebel Doeberitz M; Stallmach T
    J Pathol; 2003 Jan; 199(1):68-76. PubMed ID: 12474228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. alpha-catenin expression is decreased in human gastric cancers and in the gastric mucosa of first degree relatives.
    Yu J; Ebert MP; Miehlke S; Rost H; Lendeckel U; Leodolter A; Stolte M; Bayerdörffer E; Malfertheiner P
    Gut; 2000 May; 46(5):639-44. PubMed ID: 10764706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent loss of membranous E-cadherin in gastric cancers: A cross-talk with Wnt in determining the fate of beta-catenin.
    Cheng XX; Wang ZC; Chen XY; Sun Y; Kong QY; Liu J; Gao X; Guan HW; Li H
    Clin Exp Metastasis; 2005; 22(1):85-93. PubMed ID: 16132582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. beta-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: a study in 253 patients.
    Kildal W; Risberg B; Abeler VM; Kristensen GB; Sudbø J; Nesland JM; Danielsen HE
    Eur J Cancer; 2005 May; 41(8):1127-34. PubMed ID: 15911235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CEACAM5 has different expression patterns in gastric non-neoplastic and neoplastic lesions and cytoplasmic staining is a marker for evaluation of tumor progression in gastric adenocarcinoma.
    Liu JN; Wang HB; Zhou CC; Hu SY
    Pathol Res Pract; 2014 Oct; 210(10):686-93. PubMed ID: 25042385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis.
    Zheng Z; Pan J; Chu B; Wong YC; Cheung AL; Tsao SW
    Hum Pathol; 1999 Apr; 30(4):458-66. PubMed ID: 10208469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival.
    Jawhari A; Jordan S; Poole S; Browne P; Pignatelli M; Farthing MJ
    Gastroenterology; 1997 Jan; 112(1):46-54. PubMed ID: 8978342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-catenin expression in intramucosal neoplastic lesions of the stomach. Comparative analysis of adenoma/dysplasia, adenocarcinoma and signet-ring cell carcinoma.
    Tsukashita S; Kushima R; Bamba M; Nakamura E; Mukaisho K; Sugihara H; Hattori T
    Oncology; 2003; 64(3):251-8. PubMed ID: 12697966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus, beta-catenin, and E-cadherin in gastric carcinomas.
    Jung IM; Chung JK; Kim YA; Kim JE; Heo SC; Ahn YJ; Hwang KT; Kim BG; Lee KL; Kim CW; Kim WH; Chang MS
    J Korean Med Sci; 2007 Oct; 22(5):855-61. PubMed ID: 17982235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of E-cadherin/catenin complex expression in gastric cancer.
    Joo YE; Park CS; Kim HS; Choi SK; Rew JS; Kim SJ
    J Korean Med Sci; 2000 Dec; 15(6):655-66. PubMed ID: 11194192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic alteration of the E-cadherin/catenin complex during cell differentiation and invasion of undifferentiated-type gastric carcinomas.
    Nakamura E; Sugihara H; Bamba M; Hattori T
    J Pathol; 2005 Feb; 205(3):349-58. PubMed ID: 15682444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical patterns in rectal cancer: application of tissue microarray with prognostic correlations.
    Fernebro E; Bendahl PO; Dictor M; Persson A; Fernö M; Nilbert M
    Int J Cancer; 2004 Oct; 111(6):921-8. PubMed ID: 15300804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma.
    Bachmann IM; Straume O; Puntervoll HE; Kalvenes MB; Akslen LA
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8606-14. PubMed ID: 16361544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced membranous and ectopic cytoplasmic expression of beta -catenin correlate with cyclin D1 overexpression and poor prognosis in pancreatic cancer.
    Qiao Q; Ramadani M; Gansauge S; Gansauge F; Leder G; Beger HG
    Int J Cancer; 2001 May; 95(3):194-7. PubMed ID: 11307154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer.
    Gonzalez MA; Pinder SE; Wencyk PM; Bell JA; Elston CW; Nicholson RI; Robertson JF; Blamey RW; Ellis IO
    J Pathol; 1999 Apr; 187(5):523-9. PubMed ID: 10398116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of mismatch repair proteins, beta catenin, and E cadherin in intestinal-type sinonasal adenocarcinoma.
    Perez-Ordonez B; Huynh NN; Berean KW; Jordan RC
    J Clin Pathol; 2004 Oct; 57(10):1080-3. PubMed ID: 15452164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis.
    Chung GG; Provost E; Kielhorn EP; Charette LA; Smith BL; Rimm DL
    Clin Cancer Res; 2001 Dec; 7(12):4013-20. PubMed ID: 11751495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.
    Pirinen RT; Hirvikoski P; Johansson RT; Hollmén S; Kosma VM
    J Clin Pathol; 2001 May; 54(5):391-5. PubMed ID: 11328840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.